WB | 咨询技术 | Human,Mouse,Rat |
IF | 咨询技术 | Human,Mouse,Rat |
IHC | IHC:1/100-1/200;IHF:1/50-1/200 | Human,Mouse,Rat |
ICC | 1/50-1/200 | Human,Mouse,Rat |
FCM | 1/20-1/100 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | CDW1; DCAF2; Dtl; L2DTL; RAMP;;CDT2 |
WB Predicted band size | Calculated MW: 79 kDa ; Observed MW: 91 kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human,Mouse,Rat |
Immunogen | A synthesized peptide derived from human CDT2 |
Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是关于 **CDT2抗体** 的3篇代表性文献,简要总结研究内容:
---
1. **文献名称**: *CRL4-CDT2 ubiquitin ligase regulates replication licensing through degradation of CDT1*
**作者**: Jin J, Arias EE, Chen J, et al.
**摘要**: 本研究揭示了CRL4-CDT2复合体通过泛素化降解CDT1蛋白,调控DNA复制许可的机制。CDT2抗体被用于检测细胞周期中CDT1的动态变化,证明其在S期和DNA损伤后的降解依赖CRL4-CDT2活性。
2. **文献名称**: *A role for CRL4-CDT2 in maintaining genome stability through regulation of CDT1*
**作者**: Havens CG, Walter JC.
**摘要**: 研究利用CDT2抗体进行免疫沉淀和Western blot分析,发现CRL4-CDT2在DNA复制应激后靶向降解CDT1.防止DNA重复复制(re-replication)和基因组不稳定。该机制对细胞周期调控至关重要。
3. **文献名称**: *CRL4-CDT2: A novel axis targeting the cell cycle inhibitor p21 for degradation*
**作者**: Abbas T, Dutta A.
**摘要**: 本文发现CRL4-CDT2不仅降解CDT1.还调控p21蛋白的稳定性。通过CDT2抗体实验,证实其在细胞周期进程和癌症中的潜在作用,为靶向CRL4-CDT2的肿瘤治疗提供理论依据。
---
**备注**:以上文献均发表于2000-2010年代,涉及CDT2在DNA复制、基因组稳定性和癌症中的功能研究。如需具体年份或期刊,建议通过PubMed/Google Scholar检索作者及标题获取全文。
×